Skip to main content

Advertisement

Log in

Hepatitis B virus and hepatitis D virus in blood donors from Argentina: circulation of HBsAg and reverse transcriptase mutants

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

In Argentina, current procedures to ensure the safety of the blood supply for transfusion include the serologic detection of specific blood-borne infections. The aim of this study was to evaluate the prevalence and the genetic diversity of hepatitis B virus (HBV) and hepatitis D virus (HDV) in blood donor populations from two distantly located Argentine regions. Data from 56,983 blood donations from the Favaloro Foundation, in the city of Buenos Aires (Central Region), and the Central Blood Bank of Misiones Province (Northeast Region) were analyzed. Samples that were reactive for HBsAg were analyzed for HBV-DNA characterization and HDV serological and molecular analysis. The HBV prevalence was 0.12 % for HBsAg and 1.68 % for anti-HBc antibodies in Buenos Aires, and 0.73 % and 8.55 %, respectively, in Misiones. Seventy-seven HBsAg-reactive samples were analyzed by polymerase chain reaction for HBV-DNA. Subgenotypes A2, B2, C2, F1b and F4 (Buenos Aires) and F1b and D3 (Misiones) were detected. Several mutations within the major hydrophilic region of HBsAg, the reverse transcriptase, the basal core promoter, and the precore/core were detected. HDV genotype 1 was identified in Buenos Aires. This study confirms the circulation of several HBV subgenotypes, as well as known and newly identified variants, and the presence of HDV1 in this population. A thorough investigation has to be carried out to evaluate the clinical importance of some of the documented mutations as well as those detected in the HDV1 case.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. El-Serag H, Ruldolph K (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576. doi:10.1053/j.gastro.2007.04.061

    Article  CAS  PubMed  Google Scholar 

  2. Shih HH, Jeng KS, Syu WJ, Huang YH, Su CW, Peng WL, Sheen IJ, Wu JC (2008) Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis D virus. J Virol 82:2250–2264. doi:10.1128/JVI.02155-07

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49:45–55. doi:10.1002/hep.22898

    Article  Google Scholar 

  4. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuta M, Miyakawa Y, Mizokami M (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83:10538–10547. doi:10.1128/JVI.00462-09

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Hughes SA, Wedemeyer H, Harrison PM (2011) Hepatitis delta virus. Lancet 378:73–85. doi:10.1016/S0140-6736(10)61931-9

    Article  PubMed  Google Scholar 

  6. Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC, Dény P (2004) Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a delta virus genus of at least seven major clades. J Virol 78:2537–2544. doi:10.1128/JVI.78.5.2537-2544.2004

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Monsalve-Castillo F, Echevarría JM, Atencio R, Suárez A, Estévez J, Costa-León L, Montiel P, Molero T, Zambrano M (2008) Amerindians in Japreira, Zulia State, Venezuela. Cad Saude Pública 24:1183–1186

    Article  PubMed  Google Scholar 

  8. World Health Organization (1998) Blood bank situation in Latin America, 1996: serological markers for communicable diseases in blood donors. Epidemiol Bull 19: 12–14. Fact sheet N°204. http://www.who.int. and Pan American Health Organization (Revised August 2008)

    Google Scholar 

  9. Proyecto Programa Nacional de Control de Hepatitis Virales. Epidemiología Informe N°6-9. Instituto Nacional de Enfermedades Infecciosas (INEI). Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) “Dr. Carlos Gregorio Malbrán”. http://www.hepatitisviral.com.ar/ppnhv.htm

  10. Mathet V, Cuestas ML, Trinks J, Minassian ML, Ruiz V, Rivero CW, Andreetta AM, Weissenbacher MC, Oubiña JR (2007) Chapter X: genetic diversity and variability of Hepatitis B virus (HBV) in Latin America and the Caribbean region: implications in epidemiological, clinical, diagnostic, prophylactic and therapeutic approaches. In: Denyer DV (ed) Progress in hepatitis B. Nova Science Publishers Inc., NY, pp 277–351

    Google Scholar 

  11. Trinks J, Cuestas ML, Tanaka Y, Mathet VL, Minassian ML, Rivero CW, Benetucci JA, Gímenez ED, Segura M, Bobillo MC, Corach D, Ghiringhelli PD, Sánchez DO, Avila MM, Peralta LA, Kurbanov F, Weissenbacher MC, Simmonds P, Mizokami M, Oubiña JR (2008) Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent. J Viral Hepat 15:827–838. doi:10.1111/j.1365-2893.2008.00997.x

    CAS  PubMed  Google Scholar 

  12. França PH, González JE, Munné MS, Brandão LH, Gouvea VS, Sablon E, Vanderborght BO (2004) Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected Argentinean blood donors. J Clin Microbiol 42:5015–5021. doi:10.1128/JCM.42.11.5015-5021.2004

    Article  PubMed Central  PubMed  Google Scholar 

  13. Piñeiro Y, Leone FG, Pezzano SC, Torres C, Rodríguez CE, Eugenia Garay M, Fainboim HA, Remondegui C, Sorrentino AP, Mbayed VA, Campos RH (2008) Hepatitis B virus genetic diversity in Argentina: dissimilar genotype distribution in two different geographical regions; description of hepatitis B surface antigen variants. J Clin Virol 42:381–388. doi:10.1016/j.jcv.2008.01.018

    Article  Google Scholar 

  14. Mathet VL, Cuestas ML, Ruiz V, Minassian ML, Rivero C, Trinks J, Daleoso G, León LM, Sala A, Libellara B, Corach D, Oubiña JR (2006) Detection of hepatitis B virus (HBV) genotype E carried -even in the presence of high titers of anti-HBs antibodies- by an Argentinean patient of African descent who had received vaccination against HBV. J Clin Microbiol 44:3435–3439. doi:10.1128/JCM.00866-06

    Article  PubMed Central  PubMed  Google Scholar 

  15. Flichman D, Galdame O, Livellara B, Viaut M, Gadano A, Campos R (2009) Full-length genome characterization of hepatitis B virus genotype H strain isolated from serum samples collected from two chronically infected patients in Argentina. J Clin Microbiol 47:4191–4193. doi:10.1128/JCM.01337-09

    Article  PubMed Central  PubMed  Google Scholar 

  16. Quarleri J, Moretti F, Bouzas MB, Laufer N, Carrillo MG, Giuliano SF, Pérez H, Cahn P, Salomon H (2007) Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 23:525–531. doi:10.1089/aid.2006.0172

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Fay O, Tanno H, Gatti H, Basualdo JA, Ciocca M, Fainboin H, Fainboin L, Jorge A, Motta A, Naval M et al (1987) Anti-delta antibody in various HBsAg positive Argentine populations. J Med Virol 22:257–262

    Article  CAS  PubMed  Google Scholar 

  18. Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, Gancedo E, Castro R, Brajterman L, Laplumé H (1999) Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 6:53–57. doi:10.1046/j.1365-2893.1999.t01-1-6120135.x

    Article  CAS  PubMed  Google Scholar 

  19. Schmunis GA, Dias JC (2000) Health care reform, decentralization, prevention and control of vector-borne diseases. Cad Saude Publica 16:117–123

    Article  PubMed  Google Scholar 

  20. Lindh M, Andersson AS, Gusdal A (1997) Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175:1285–1293

    Article  CAS  PubMed  Google Scholar 

  21. Birkenmeyer L, Mushahwar I (1994) Detection of hepatitis A, B and D virus by the polymerase chain reaction. J Virol Methods 49:101–112

    Article  PubMed  Google Scholar 

  22. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WG (2001) A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 82:883–892

    CAS  PubMed  Google Scholar 

  23. Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339(6221):237–238

    Article  CAS  PubMed  Google Scholar 

  24. Mathet VL, Feld M, Espinola L, Sanchez DO, Ruiz V, Mando O, Carballal G, Quarleri JF, D’Mello F, Howard CR, Oubina JR (2003) Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies. J Med Virol 69:18–26

    Article  CAS  PubMed  Google Scholar 

  25. Nakano T, Shapiro CN, Hadler SC, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH (2001) Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 82:2183–2189

    CAS  PubMed  Google Scholar 

  26. Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, Mullenbach GT, Denniston KJ, Gerin JL, Houghton M (1986) Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 323:508–514

    Article  CAS  PubMed  Google Scholar 

  27. Delfino CM, Eirin ME, Berini C, Malan R, Gentile E, Castillo A, Pedrozo W, Krupp R, Blejer J, Oubiña JR, Mathet VL, Biglione MM (2012) HDAg-L variants in covert hepatitis D and HBV occult infection among Amerindians of Argentina: new insights. J Clin Virol 54:223–228. doi:10.1016/j.jcv.2012.04.014

    Article  CAS  PubMed  Google Scholar 

  28. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTALX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599

    Article  CAS  PubMed  Google Scholar 

  30. Shi W, Zhang Z, Ling C, Zheng W, Zhu C, Carr MJ, Higgins DG (2013) Hepatitis B virus subgenotyping: History, effects of recombination, misclassifications, and corrections. Infect Genet Evol 16:355–361. doi:10.1016/j.meegid.2013.03.021

    Article  CAS  PubMed  Google Scholar 

  31. Delfino CM, Berini C, Eirin ME, Malan R, Pedrozo W, Krupp R, Blejer J, Espejo R, Fierro L, Puca A, Oubiña JR, Mathet VL, Biglione MM (2012) New natural variants of hepatitis B virus among Amerindians from Argentina with mainly occult infections. J Clin Virol 54:174–179. doi:10.1016/j.jcv.2012.02.023

    Article  PubMed  Google Scholar 

  32. Reis LM, Soares MA, França PH, Soares EA, Bonvicino CR (2011) Clonal analysis of hepatitis B viruses among blood donors from Joinville, Brazil: evidence of dual infections, intragenotype recombination and markers of risk for hepatocellular carcinoma. J Med Virol 83:2103–2112. doi:10.1002/jmv.22246

    Article  PubMed  Google Scholar 

  33. Yousif M, Kramvis A (2012) Genotype D of hepatitis B virus and its subgenotypes: An update. Hepatol Res 43(4):355–364. doi:10.1111/j.1872-034X.2012.01090.x

    Article  PubMed  Google Scholar 

  34. Pezzano SC, Torres C, Fainboim HA, Bouzas MB, Schroder T, Giuliano SF, Paz S, Alvarez E, Campos RH, Mbayed VA (2011) Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes. Clin Microbiol Infect 17:223–231. doi:10.1111/j.1469-0691.2010.03283.x

    Article  CAS  PubMed  Google Scholar 

  35. Khan A, Tanaka Y, Saito H, Ebinuma H, Sekiguchi H, Iwama H, Wakabayashi G, Kamiya T, Kurbanov F, Elkady A, Mizokami M (2008) Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. Virus Res 132:174–180. doi:10.1016/j.virusres.2007.12.005

    Article  CAS  PubMed  Google Scholar 

  36. López JL, Mbayed VA, Telenta PF, González JE, Campos RH (2002) ‘Hbe minus’ mutants of hepatitis B virus. Molecular characterization and its relation to viral genotypes. Virus Res 87:41–49. doi:10.1016/S0168-1702(02)00078-3

    Article  PubMed  Google Scholar 

  37. Tan YJ (2011) Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 17:4853–4857. doi:10.3748/wjg.v17.i44.4853

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Cao GW (2009) Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 15:5761–5769. doi:10.3748/wjg.15.5761

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Svicher V, Cento V, Bernassola M, Neumann-Fraune M, Van Hemert F, Chen M, Salpini R, Liu C, Longo R, Visca M, Romano S, Micheli V, Bertoli A, Gori C, Ceccherini-Silberstein F, Sarrecchia C, Andreoni M, Angelico M, Ursitti A, Spanò A, Zhang JM, Verheyen J, Cappiello G, Perno CF (2012) Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res 93:86–93. doi:10.1016/j.antiviral.2011.10.022

    Article  CAS  PubMed  Google Scholar 

  40. Mangold CM, Unckell F, Werr M, Streeck RE (1995) Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535–543. doi:10.1006/viro.1995.1435

    Article  CAS  PubMed  Google Scholar 

  41. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, Locarnini SA, Fyfe J, Sozzi T, Jackson DC (2002) Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase genes that are selected by lamivudine therapy. Virology 293:305–313. doi:10.1006/viro.2001.1246

    Article  CAS  PubMed  Google Scholar 

  42. Shaw T, Bartholomeusz A, Locarnini S (2006) HBV drug resistance: mechanisms, detection and interpretation. J Hepatol 44(3):593–606

    Article  CAS  PubMed  Google Scholar 

  43. Sheldon J, Ramos B, Garcia-Samaniego J, Rios P, Bartholomeusz A, Romero M, Locarnini S, Zoulim F, Soriano V (2007) Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. J Acquir Immune Defic Syndr 46(3):279–282

    Article  PubMed  Google Scholar 

  44. Kim do Y, Chang HY, Lim SM, Kim SU, Park JY, Kim JK, Lee KS, Han KH, Chon CY, Ahn SH (2013) Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 7(3):329–334. doi:10.5009/gnl.2013.7.3.329

    Article  PubMed Central  PubMed  Google Scholar 

  45. Liu BM, Li T, Xu J, Li XG, Dong JP, Yan P, Yang JX, Yan L, Gao ZY, Li WP, Sun XW, Wang YH, Jiao XJ, Hou CS, Zhuang H (2010) Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. Antiviral Res 85:512–519. doi:10.1016/j.antiviral.2009.12.006

    Article  CAS  PubMed  Google Scholar 

  46. Cuestas ML, Rivero CW, Minassian ML, Castillo AI, Gentile EA, Trinks J, León L, Daleoso G, Frider B, Lezama C, Galoppo M, Giacove G, Mathet VL, Oubiña JR (2010) Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina. Antiviral Res 87:74–77. doi:10.1016/j.antiviral.2010.04.005

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful for the invaluable assistance provided by Horacio Salamone and Ramón Krupp during manuscript preparation. This work was supported by funds from B.I.D. 1728/OC-AR PICT 2007 01639 (Scientific and Technologic Research Projects), Fundación Florencio Fiorini; UBACyT 20020100101063 and 20020090200189, (University of Buenos Aires), Buenos Aires, Argentina, and CONICET PIP 112-200801-01773 and from Département de Virologie, Unité d’épidémiologie et physiopathologie des virus oncogènes, Institut Pasteur, Paris, France.

Conflict of interest

No conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cecilia María Delfino.

Additional information

M. M. Biglione and V. L. Mathet contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delfino, C.M., Gentile, E.A., Castillo, A.I. et al. Hepatitis B virus and hepatitis D virus in blood donors from Argentina: circulation of HBsAg and reverse transcriptase mutants. Arch Virol 159, 1109–1117 (2014). https://doi.org/10.1007/s00705-013-1917-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-013-1917-y

Keywords

Navigation